Home
About
Overview
Sharing Data
ORCID
Help
History (2)
No Cell Left Behind: Using Embryoid Bodies to Understand Human Biology
Xevinapant or placebo plus chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck: TrilynX phase III study design.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
No Cell Left Behind: Using Embryoid Bodies to Understand Human Biology
Overview
sponsor award id
R21HG011170
Biography
contributor
Principal Investigator
Time
start date
2022-07-01
end date
2024-06-30